Moderna Announces Preliminary Booster Data, Updates Strategy to Address COVID-19 Variant Omicron
The currently authorized 50 ”g booster of mRNA-1273 increased antibody levels against Omicron variant approximately 37-fold compared to pre-boost levels and a 100 ”g dose of mRNA-1273 increased antibody levels approximately 83-fold compared to pre-boost levels.
Moderna on Monday announced preliminary neutralizing antibody data against the Omicron variant following the Companyâs booster candidates at 50 ”g and 100 ”g dose levels. As per Moderna, the currently authorized 50 ”g booster of mRNA-1273 increased antibody levels against Omicron variant approximately 37-fold compared to pre-boost levels and a 100 ”g dose of mRNA-1273  increased antibody levels approximately 83-fold compared to pre-boost levels.
Check Tweet:
The authorized 50 ”g booster of mRNA-1273 increased neutralizing antibody levels against Omicron ~37-fold compared to pre-boost levels & a 100 ”g dose of mRNA-1273 increased neutralizing antibody levels ~83-fold compared to pre-boost levels. Read more: https://t.co/4WiCSwJn6B pic.twitter.com/5big1gH6cN
â Moderna (@moderna_tx) December 20, 2021
(The above story first appeared on LatestLY on Dec 20, 2021 04:41 PM IST. For more news and updates on politics, world, sports, entertainment and lifestyle, log on to our website latestly.com).
